Back to Trades
Total Value
$0
Filing Date
Jul 10, 2026
1 transactions
Trade Summary
On Jul 8, 2026, Hagler Mark Arnold, Insider, reported $0 of NovaBridge Biosciences (NBP) across 1 transactions. The filing covers company securities and reflects balanced net activity of $0. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- NovaBridge Biosciences
- Ticker Symbol
- NBP
- CIK
- 0001778016
Insider Information
- Role
- Insider
- Location
- ROCKVILLE, MD
Filing Details
- Filing Date
- Jul 10, 2026
- Transaction Date
- Jul 8, 2026
- Accession Number
- 0002126029-26-000003
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | NBP derivative | 949,050 | — | Grant/Award | — |
Want live alerts when Hagler Mark Arnold trades again?
Download Insider Trades to track NBP, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Number of underlying securities and exercise price expressed in terms of American Depositary Shares ("ADS").
- (F2)The option vests and becomes exercisable in four equal annual installments beginning on the first anniversary of April 17, 2026.
- (F3)The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer.